Huntsman Corporation Stock 12‑Month Price Target Cut to $10.94, Implies 27% Upside

Huntsman Corporation's average stock price target was reduced from $11 to $10.94 by 16 analysts, with forecasts ranging from $9 to $15. This implies a 27% upside from the Oct. 16 closing price. The consensus rating remains 'Hold' among 19 analysts, with 4 'Buy', 13 'Hold', and 2 'Sell' ratings.

Original reporting
Published Oct 19, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 4:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Huntsman Corporation Stock 12‑Month Price Target Cut to $10.94, Implies 27% Upside — source image
Decision brief

The 30-second read

$HUNBearishLow
01

Why it matters

The target reduction may trigger short-term selling pressure, but the still‑high implied upside could support a rebound if new positive news emerges.

02

Market read

Analyst target change provides modest trading signal for HUN shareholders and short‑term traders.

03

What to watch

Potential hidden catalysts such as upcoming contract wins or cost reductions not reflected in the target.

Relevance 5/10Novelty 4/10Timing: today

Background

Huntsman Corporation is a US-listed specialty chemicals producer (NYSE: HUN). The article reports a recent analyst consensus price target adjustment.

Company-level read

Ticker impact

$HUNBearishMedium confidence
Context

Analyst consensus price target lowered to $10.94, down from $11, indicating a fresh downgrade in expectations.

Expected impact

likely pressure as market prices in the lower target

Evidence & confidence

Analyst price target reductions typically lead to short-term sell pressure, even if upside remains.

Market effects

Minor impact on specialty chemicals sector as peers may see similar target revisions.

Limited to US-listed specialty chemicals investors.

Low global relevance.

Counterpoint

Despite the target cut, the implied 27% upside may attract value buyers.

Key entities

  • Huntsman Corporation

    Specialty chemicals manufacturer

Related articles

$HUNMed

KeyBanc raises Huntsman stock price target on merger synergies

KeyBanc raised its price target for Huntsman (NYSE:HUN) to $13, citing merger synergies with OLN and better-than-expected Q3 results. The stock trades at $9.45, with a Fair Value of $13.16. Huntsman reported mixed Q3 earnings, missing EPS estimates but exceeding revenue forecasts. Jefferies initiated coverage with a Buy rating and $12 target. The company faces rising input costs but aims for $100M EBITDA improvement in 2026.

$HUNMed

Huntsman Q3 Earnings Call Highlights

Huntsman (HUN) reported Q3 earnings, noting seasonal slowing and higher raw-material costs in North American MDI markets. The company expects 2027 industry MDI growth to be flat to 2% and sees growth opportunities in advanced materials and automotive applications. Huntsman generated $82M in free cash flow in Q3 and anticipates substantial cash inflow in Q4. Europe remains challenging due to high energy costs, while China's market shows stability.

$HUNMed

Huntsman Corp (HUN) (Q3 2026) Earnings Call Highlights: $100 Million EBITDA Boost

Huntsman Corp (HUN) reported a $100M EBITDA boost in Q3 2026, with CEO Peter Huntsman expressing confidence in meeting $300M synergy targets from the Olin merger. He discussed market positioning, cost management, and growth expectations, including GDP-plus growth in Advanced Materials through 2027. The company expects to cover its dividend and capex with operating cash flow, despite minimal cash flow in the first nine months.

$HUNMedAI 8/10

Huntsman: Q3 Earnings Snapshot

Huntsman Corp. (HUN) reported a Q3 loss of $18M, or 10 cents per share, missing analyst expectations of 7 cents per share. Adjusted earnings were 4 cents per share. Revenue was $1.72B, exceeding forecasts of $1.6B.